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Depressive disorders are a curable, global health problem. However, most patients
remain untreated, and more and more patients use internet-based interventions, but
it is unclear whether it is beneficial for ongoing face-to-face psychotherapy. Thus, we
compared the outcome of internet cognitive behavioral therapy (ICBT) with (ICBT+) or
without (ICBT) additional face-to-face outpatient psychotherapy in adult patients with
moderate to severe depressive disorder. For this longitudinal interventional clinical trial
(NCT02112266), 168 of 252 online recruited adults with depressive symptoms received
ICBT+ (n = 96) or ICBT (n = 72). Demographics (sex, age, age at first depressive
episode, years of education, duration of depressive symptoms) were assessed and
compared between groups. All patients underwent ICBT for 12 weeks. Quality of life
(QoL) and severity of depressive symptoms were assessed within each group at three
time points [baseline (T0), postinterventional after ICBT at 12weeks (T1), and for follow-up
at 6 months (T2)] using the World Health Organization Quality of Life Questionnaire
(WHOQOL-BREF) global score to assess QoL as primary and the Beck Depression
Inventory (BDI-II) to assess self-rated depressive symptoms as secondary outcome
variables, respectively. Differences were assessed between groups using t test and over
time using repeated-measures analysis of variance. Data of intention-to-treat analysis are
given as mean ± SD. Group differences were assumed at p < 0.05. Partial η2 is given
as effect size. Demographic data, QoL, and depressive symptoms did not differ between
groups (ICBT+/ICBT) at baseline (T0). Patients of both groups suffered from moderate to
severe depressive disorders and gained improved QoL scores (WHOQOL-BREF-global:
p < 0.001, η2 = 0.16), as well as experienced decreased depressive symptoms (BDI-II:
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p < 0.001, η2 = 0.2) after 12 weeks of ICBT compared to baseline. Patients without
additional face-to-face outpatient psychotherapy lost QoL—albeit not significant—and
had increased depressive symptoms (BDI: p = 0.02, η2 = 0.04) at 6 months’ follow-up.
Thus, ICBT is suitable for psychiatric treatment, although additional face-to-face
outpatient psychotherapy helps stabilizing long-term outcome.
Keywords: depression, ICBT, face-to-face psychotherapy, QoL, BDI-II, WHOQOL-BREF, trial
INTRODUCTION
Depressive disorders are a major, though curable, global health
problem that remarkably hampers patient’s quality of life (QoL).
The World Health Organization (WHO) has ranked major
depression worldwide the third cause of burden, and it is
estimated to be the primary cause by 2030 (1, 2). The lifetime
risk is 15–18%, and women are twice as often affected as men
(3, 4). However, prior to puberty, affective disorders are equally
distributed between sexes, but notably, this sex- and gender-
related difference in the prevalence of depression occurs during
adolescence and remains stable over the life span, indicating
besides genetic factors a role of sex hormones and/or gender-
related educational issues for the pathogenesis (5, 6). Depression
is similarly prevalent in high- vs. middle- and low-income
countries indicating that causes go far beyond modern lifestyle
and poverty (2, 7, 8). Nevertheless, a remarkable number of
patients remain undiagnosed (9–11), and almost half remain
untreated (12, 13). Reasons for not seeking professional help are
unawareness with failure of recognizing depressive symptoms,
the limited capacities of therapists, and the persisting tenacious
stigma of mental disorders (10, 12–14). This treatment gap is
especially relevant in the young, thereby increasing the risk of
progression in terms of recurrence and aggravation of episodes
in adulthood, and endures despite the large body of effective non-
pharmacological and pharmacological treatment (10, 15–17).
Psychotherapy effectively tackle mild to moderate depressive
disorders, whereas moderate to severe depression needs a
combined approach of pharmacotherapy and psychotherapy
(18). To date, cognitive behavioral therapy (CBT) is the
most evidence-based psychotherapy for depression (13, 19),
and patients often prefer non-pharmacological rather than
pharmacological or combined approaches. Recently, online
therapies gained more attention to close the current treatment
gap for depressive disorders (13, 20, 21). Internet-based
cognitive behavioral interventions, such as the internet cognitive
behavioral therapy (ICBT), improve mild to moderate depressive
symptoms and have been shown to be beneficial when
compared to usual care either by the general practitioner or
a psychotherapist without grading of the evidence [Grading
Abbreviations: BDI-II, Beck Depression Inventory, 2nd version; CBT, Cognitive
Behavioral Therapy; GRADE, Grading of Recommendations Assessment,
Development and Evaluation; ICBT, Internet Cognitive Behavioral Therapy;
ICBT+, Internet Cognitive Behavioral Therapy plus additional face-to-face
outpatient psychotherapy; η2, Partial eta squared (effect size); QoL, Quality of Life;
SD, Standard Deviation; WHO, World Health Organization; WHOQOL-BREF,
World Health Organization Quality of Life Questionnaire.
of Recommendations Assessment, Development and Evaluation
(GRADE) not conducted] and in comparison to waiting-list
patients with moderate evidence (GRADE moderate) (22).
However, there is also the contrary opinion and evidence
that ICBT might be inferior regarding individual and face-to-
face outpatient CBT (21). Nevertheless, the evidence of ICBT
improving severe depressive symptoms is rare (23), and to our
knowledge, ICBT has not yet been compared to ICBT plus face-
to-face psychotherapy in moderate to severe depression (22).
Thus, evidence regarding QoL outcome and relief of symptoms
in moderate to severe depressive patients has not yet been
fully explored.
Quality of life is a suitable and increasingly applied subjective
outcome measure to assess patient’s well-being over time. The
WHOdefines QoL as “an individual’s perception of their position
in life in the context of the culture and value systems in which
they live and in relation to their goals, expectations, standards,
and concerns. It is a broad-ranging concept with complex
interactions with a person’s physical health, psychological state,
personal beliefs, social relationships, and their relationship to
salient features of their environment,” (24) thereby emphasizing
the relevance of internal and environmental factors and its
interplay for good QoL.
Currently, more and more internet-based interventions are
available and are used by patients with or without ongoing face-
to-face psychotherapy. Nevertheless, it is unclear whether these
internet-based interventions are favorable or even unfavorable
due to different therapy approaches at the same time. Therefore,
we investigated the outcome of ICBT with or without additional
face-to-face outpatient psychotherapy in adult patients with a
moderate to severe depressive disorder.
PATIENTS AND METHODS
Study Design and Patients
This longitudinal interventional preregistered clinical trial
(NCT02112266) was conducted online. A multipronged
approach included several recruitment strategies, namely,
announcements on depressive disorder websites, postings in
online self-help forums, and notices in chat rooms for depressive
symptoms. Patients were enrolled online from April 2014
until March 2016. After the presurvey, potentially eligible
subjects received a participation code. All online questionnaires
were programmed using QuestBack Unipark (25). After final
study inclusion, patients were assigned to the ICBT group
receiving exclusively the ICBT online therapy or to the ICBT+
group receiving ICBT plus additional face-to-face outpatient
Frontiers in Digital Health | www.frontiersin.org 2 June 2020 | Volume 2 | Article 4
Rauen et al. ICBT Improves QoL and Depression
psychotherapy. All patients underwent ICBT for 12 weeks
without study site visits, thus from T0 until T1. Therefore, time
points of assessments were at baseline (T0), after 12 weeks of
the ICBT treatment (T1), and at 6 months after the start of
the ICBT treatment for one follow-up (T2). Demographics
(sex, age, age at first depressive episode, years of education,
duration of depressive symptoms) were assessed and compared
between groups at baseline (T0). Changes of QoL as primary
outcome were measured by the World Health Organization
Quality of Life Questionnaire (WHOQOL-BREF) global score.
Depressive symptoms were quantified with the BDI-II as
secondary outcome. Primary and secondary outcomes were
assessed over time at three time points, that is, at baseline
(T0), after the intervention of ICBT at 12 weeks (T1), and
at 6 months’ follow-up (T2). The study was approved by the
local ethics committee of the Canton of Zurich in Switzerland
(KEK-ZH-Nr. 2013-0542). It was conducted in full accordance
with the Declaration of Helsinki, with all subjects providing
their electronic informed consent prior to participation and the
EQUATOR/CONSORT standards.
Inclusion and Exclusion Criteria
Patients aged 18–65 years of both sexes (female/ male) were
eligible for study inclusion if depressive symptoms were at
least moderate to severe with a BDI-II equal to or >20 and
<40, and symptoms persisted at least for 2 weeks. German
language was required. Exclusion criteria were very severe
depression according to a BDI-II of beyond 40, suicidal
ideation, alcohol or drug dependency, history of psychotic
symptoms, history of bipolar disorder, current inpatient care, or
semiresidential treatment.
Intervention
Both groups received the ICBT over 12 weeks, developed
by makora AG (www.makora.ch). Subjects were allocated to
this internet intervention, including eight different modules,
which were released every week. All modules were based
on psychoeducation and exercises for the following topics:
(1) symptom recognition, (2) identification of reasons for
depressive symptoms, (3) increasing positive activation, (4)
thought observation, (5) thought identification, (6) error in
reasoning resolving, (7) social activity improving, and (8) relapse
preventing. There was no personal study support other than
technical. However, subjects received automatic e-mails when
(i) they did not finish an ICBT module, (ii) did not log in into
the program for more than 7 days, and (iii) a new module was
released to work on. After the 12 weeks of ICBT, thus between
the end of the ICBT (T1) and the follow-up at 6 months (T2),
subjects could use the ICBT program without any restrictions.
During this period, they received no more automatic e-mails but
were occasionally reminded that they were taking part in a study.
There were neither recommendations nor restrictions during the
3-months period from the end of the structured and guided ICBT
(T1) to the follow-up, thus at 6 months after the start of the
trial (T2). Therefore, all participants were able to continue or
discontinue ICBT in accordance to their individual motivation
and preferences, and patients of the ICBT+ group could follow
their individual needs regarding the face-to-face psychotherapy.
Demographics and Outcome Measures
Sociodemographic and clinical data were obtained through
structured questions about sex (female/male), age, age at
first depressive episode, years of education, and duration of
depressive symptoms and were compared between groups at
baseline (T0).
The WHOQOL-BREF in its German version was used to
assess QoL for primary outcome over time within and between
groups (26). The WHOQOL-BREF is a validated patient-
reported outcome instrument assessing the patient’s global health
and well-being within the recall period of 2 weeks and has
been developed to provide a validated short form covering 26
items and all facets of the WHOQOL-100—one of the most
applied QoL assessments. Despite its significant reduction in
questions compared to the WHOQOL-100, the WHOQOL-
BREF is a sound, cross-culturally valid instrument with good to
excellent psychometric properties with the advantage of quick
completion (26, 27). The WHOQOL-BREF generates a QoL
profile of four domains, namely, physical health, psychological,
social relationships, environment, and two further items, that
is, the individual’s overall perception and the global health
with a score from 0 to 100 representing worst and best
QoL, respectively.
The BDI-II was used for secondary outcome measures
assessing depressive symptoms over time within and between
groups. The BDI-II is a self-assessment and can be completed
within 5 to 10min (28, 29). The questionnaire consists of 21
items, each rated on a 4-point scale ranging from 0 to 3,
representing no to severe symptoms within the past 2 weeks.
Responses were summed, yielding a score between 0 and 63, with
higher scores indicating severest depressive symptoms. In detail,
a score from 0 to 8 represents no clinical signs of depression; a
score of 9 to 13, minimal; a score of 14 to 19, mild; a score of
20–28, moderate; and a score of 29–63, severe depression. The
BDI-II is reliable with a Cronbach α of 0.93 for depressed patients
and has a good internal and external test validity with r = 0.72–
0.89 and r = 0.68–0.70, respectively. Instruments’ responsiveness
is along reliability and validity one out of the three measurement
properties to determine the quality of a health-related patient-
reported outcome and represents the capability to detect the
patient status’ changes over time (30, 31)
Statistics
Descriptive statistics were used to characterize subjects regarding
demographics and therapy characteristics of the ICBT and
the ICBT+ group. Differences (demographics, WHOQOL-
BREF global score, BDI-II) at baseline were assessed per
group using t test for independent samples and over time
using repeated-measures analysis of variance. Intention-to-treat
analysis with first observations carried forward was conducted
for the dependent variables WHOQOL-BREF global score
and the BDI-II. Group (ICBT vs. ICBT+) served as the
between-subject variable, with time (pre, post, follow-up) as
the within-subject factor. Data are given as mean ± SD.
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FIGURE 1 | Flowchart of enrollment and analysis for ICBT.
Outliers were removed if data exceeded more than 2 SD.
Group differences were assumed at p < 0.05. To determine
effect sizes, a partial η2 was calculated, indicating a small
(η2 ≥ 0.01), medium (η2 ≥ 0.06), or large effect (η2 ≥
0.14) (32). Statistical calculations were performed using SPSS
(version 25.0; IBM, Armonk, New York, USA). Graphs were
illustrated using Prism8 (GraphPad Software, San Diego, CA,
USA) (33).
RESULTS
Two hundred fifty-two online recruited adults with depressive
symptoms were assessed for eligibility (Figure 1). Eighty-four
patients were excluded according to the exclusion criteria:
current suicidal ideation (n = 26), inpatient treatment (n = 2),
alcohol or drug dependency (n = 7), psychotic symptoms (n =
2), bipolar disorder (n = 4), not given e-mail address (n = 27),
and not willing to participate (n = 16). Thus, 168 of 252 (67%)
received participant codes to enter the online therapy. Of those,
96 (57%) had no outpatient psychotherapy and were allocated to
the ICBT group, whereas 72 had outpatient treatment for their
depressive disorder and were assigned to the ICBT+ group. After
removal of eight and five outliers, respectively, 88 patients of the
ICBT and 67 patients of the ICBT+ group were analyzed for their
primary outcome (WHOQOL-BREF global score). For secondary
outcome (BDI-II), 95 patients of the ICBT, and 69 patients of
the ICBT+ group were analyzed after removing one and three
outliers, respectively.
Frontiers in Digital Health | www.frontiersin.org 4 June 2020 | Volume 2 | Article 4
Rauen et al. ICBT Improves QoL and Depression







Sex (females/males) (%) 76%/24% 79%/21% 0.71
Age in years (mean ± SD) 35.4 ± 11.5 37.5 ± 11.9 0.26
Age at first depressive episode in
years (mean ± SD)
21.0 ± 9.6 21.7 ± 14.3 0.73
Years of education (mean ± SD) 14.6 ± 5.4 15.9 ± 5.0 0.11
Depressive symptoms in weeks
(mean ± SD)
68.2 ± 159.7 73.4 ± 151.0 0.83
#t-test after Shapiro-Wilk-Test for normality.
FIGURE 2 | Internet cognitive behavioral therapy and quality of life outcome.
Internet cognitive behavioral therapy (ICBT) is suitable to improve quality of life
(QOL) measured by the WHOQOL-BREF global score within 12 weeks of
treatment (p < 0.001, η2 = 0.16). Patients who received additional
face-to-face outpatient psychotherapy (ICBT+) were able to stabilize their
gained QoL up to 6 months after the start of the intervention, whereas patients
without additional face-to-face psychotherapy slightly lost QoL, although not
significant. *indicates the significant longitudinal improvement of QoL between
baseline (T0) and after 12 weeks of treatment (T1), and thus between T0 and
T1 within both groups.
Demographics and Therapy
Characteristics
Demographics, namely sex (female/ male), age, age at first
depressive episode, years of education, and duration of depressive
symptoms, were assessed at baseline and did not differ between
groups, that is, the ICBT (n= 96) and the ICBT+ (n= 72) group
(Table 1).
The ICBT and ICBT+ groups did not statistically differ
regarding (i) the total time spent for ICBT, (ii) the total counts of
logins, (iii) the counts of logins between T0 and T1, and (iv) the
counts of logins between T1 and T2. In detail, total time spent
for ICBT was on average in the ICBT group 4.5 ± 6.3 h (mean
± SD) and in the ICBT+ group 5.7 ± 9.3 h (p = 0.36). The
total count of logins was on average 11.5 ± 12.6 within the ICBT
group compared to 12.7 ± 14.8 (p = 0.62) within the ICBT+
group. Between T0 and T1, subjects of the ICBT group had 10.7
± 11.4 compared to 11.3 ±12.3 logins of the ICBT+ subjects
(p= 0.79). During T1 and T2, the count of logins was 0.78 ±
1.8 within the ICBT and 1.1 ± 2.9 within the ICBT+ group (p =
0.46), representing the low tendency to continue the ICBT, that is,
only 19 and 15 subjects, respectively. Frequencies of face-to-face
psychotherapy within the ICBT+ group were as follows: 43.7%
of subjects received face-to-face psychotherapy at least once per
week, 42.3% one to two times permonth, and 14.1% less frequent.
Quality-of-Life Outcome
The WHOQOL-BREF global scores did not differ between
groups (ICBT: n = 88/ ICBT+: n = 72) at baseline (36.4 ±
13.9/36.2 ± 11.9; p = 0.94) (Figure 2 and Table 2). Intention-
to-treat analysis comparing WHOQOL-BREF global scores at
T0 and T1 revealed significant improved QoL within groups
(p < 0.001) with a large effect size indicated by a partial η2 =
0.16, but without group differences (p= 0.87; η2 < 0.01). Subjects
of the ICBT group reported reduced QoL at 6 months (T2)
compared to the end of the ICBT at 12 weeks (T1), albeit this
observation was not significant within groups (p = 0.62, η2 <
0.01) or between groups (p= 0.49, η2 < 0.01).
Depressive Symptoms
The BDI-II scores did not differ between groups (ICBT: n = 95/
ICBT+: n = 69) at baseline (27.4 ± 7.7/27.6 ± 7.1; p = 0.97)
(Figure 3 and Table 3). Intention-to-treat analysis comparing
BDI-II scores at T0 and T1 underlines reduced depressive
symptoms in both groups with p < 0.001 indicated by a large
effect size with a partial η2 = 0.2. Subjects of the ICBT group
showed slight deterioration of depressive symptoms, with higher
BDI-II scores compared to those subjects of the ICBT+ group
at 6 months (T2) and compared to the end of the ICBT at 12
weeks (T1) (p = 0.02, η2 = 0.04). Thus, BDI-II scores differed
within groups over time from T0 to T1, and between groups over
time from T1 to T2, indicating a beneficial effect of additional
face-to-face outpatient psychotherapy.
DISCUSSION
This longitudinal interventional clinical trial included adult
patients aged 18–65 years of both sexes with moderate to severe
depressive disorders investigating QoL outcome measured by
the WHOQOL-BREF global score for primary and changes
of self-assessed depressive symptoms measured by the BDI-II
for secondary outcome. Demographics and outcome measures,
that is, QoL and BDI scores, did not differ at baseline
between the two investigated groups, that is, the ICBT and
ICBT+ groups, the latter having received additional face-
to-face outpatient psychotherapy, whereas the ICBT group
received solely the online treatment of eight modules on
psychoeducation and exercises. Patients of both groups, namely,
ICBT and ICBT+, reported improved QoL and had reduced
self-assessed depressive symptoms after 12 weeks (T1) of online
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TABLE 2 | Influence of ICBT on quality of life outcome.
Primary outcome Baseline (T0) Post-intervention
12 weeks (T1)
















T0 vs. T1 T1 vs. T2
WHOQOL-BREF global
(mean ± SD)











ITT analysis (N = 155) General linear models (repeated measures).
η
2: effect size partial eta squared (≥ 0.01 small effect, ≥ 0.06 medium effect, ≥ 0.14 large effect).
treatment with or without additional face-to-face outpatient
psychotherapy, and this result did not differ between the
two groups. At follow-up (T2), namely, 6 months after the
trial’s start, there was a trend that patients receiving additional
face-to-face outpatient psychotherapy (ICBT+) were able to
stabilize their QoL, whereas lack of face-to-face outpatient
psychotherapy (ICBT) might result in reduced QoL over time.
In terms of self-assessed depressive symptoms at 6 months’
follow-up, patients receiving exclusively online treatment slightly
deteriorated, whereas patients with additional face-to-face
outpatient psychotherapy further improved over time and
reported significantly fewer depressive symptoms compared to
the ICBT patients. These results suggest that additional face-
to-face outpatient psychotherapy may have helped stabilizing
outcome over time. Internet cognitive behavioral therapy
can help improve QoL and depressive symptoms especially
for those patients having limited access to psychotherapy
and/or being afraid of psychiatry-related stigma, thereby being
supportive to overcome lack of treatment capacities or stigma of
psychiatric consultations.
Demographics
The participating patients most probably suffered from recurrent
depressive disorders with onset during their adolescence and
were within their third life decade with a female-to-male ratio
of 4:1. From the literature, it is well-known that first episodes
of depressive disorders occur from midadolescence to mid-
40s, with almost half of patients experiencing first depression
before the age of 20 years with peaks in the second and third
decades of life (2); thus, our study cohort is well in line with
the literature regarding age at study participation and age at first
depressive episode. Regarding the female-to-male ratio, our study
cohort had three times more women than men; thus, women
are overrepresented in our study compared to the prevalence of
depression mostly given in the literature (2–4, 6, 34). However,
socioeconomic factors play a role for depression, and significant
cross-national variations with higher percentage of women, thus
comparable to our cohort, have been reported (35). As the
prevalence of depression changes between females and males
during adolescence and remains stable over the life span, the
biological sex due to hormonal changes and differences of brain
structures as well as gender-related factors are relevant (6, 35). It
is especially noteworthy that the association of higher education
with better mental health is significantly more relevant for
women than for men in Europe (35). Why most probably an
FIGURE 3 | Internet cognitive behavioral therapy and depressive symptoms.
Internet cognitive behavioral therapy (ICBT) is suitable to improve depressive
symptoms measured by the Beck Depression Inventory in its revised version
(BDI-II) within 12 weeks of treatment (p < 0.001, η2 = 0.2). Patients who
received additional face-to-face outpatient psychotherapy (ICBT+) further
improved and reported fewer depressive symptoms, whereas those without
additional psychotherapy deteriorate up to 6 months after the intervention
(p = 0.02, η2 = 0.04). Thus, ICBT with additional face-to-face outpatient
psychotherapy seems to be beneficial for patients to reduce depressive
symptoms in the long run. *indicates the significant longitudinal decrease of
depressive symptoms between baseline (T0) and after 12 weeks of treatement
(T1), and thus between T0 and T1 within both groups. **indicates the
significant difference between ICBT and ICBT+ groups with respect to time
from T1 to T2, thus the end of the guided ICBT treatment for both groups and
the 6 months follow up with significant less depressive symptoms in patients
having received ICBT plus face-to-face psychotherapy.
overrepresented number of women participated in our study
remains unclear, but it can be speculated that females rather
than males recognize depressive symptoms and might be more
self-aware of symptoms, and thus seeking help more frequently.
Future research should focus on how to better reach males and
younger participants suffering from depression (e.g., with specific
advertisement for online treatment for these subgroups). Based
on our results, specific suggestions for additional face-to-face
outpatient psychotherapy might be offered to participants during
the ICBT training.
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ITT analysis (N = 164) General linear models (repeated measures).
η
2: effect size partial eta squared (≥ 0.01 small effect, ≥ 0.06 medium effect, ≥ 0.14 large effect).
Quality of Life and Depression
Quality of life was connotatively hampered by moderate to severe
depression in our patients and was significantly improved in
both groups by ICBT. However, norm values of QoL measured
by the WHOQOL-BREF have been described beyond a score
of 70 (36), albeit norm data for the global score are missing.
However, the international validation of the WHOQOL-BREF
included 11,830 subjects and revealed mean values of 3–4 on
the 5-point scale for the general QoL and general health with
moderate correlations with the four domains, that is, physical,
psychological, social, and environment of the WHOQOL-BREF
(27, 37). Furthermore, other commonly used health-related QoL
scores, e.g., the SF-36, have well-reported norm values for, e.g.,
the German population with mean scores of approximately 50
on a scale ranging from 0 to 100, the latter representing best
QoL (38). Thus, most probably QoL of our patient cohort was
still hampered after ICBT with or without additional face-to-
face outpatient psychotherapy. Most likely, this impeded QoL is
influenced by the long average duration of depressive symptoms;
that is, patients of our cohort have cumulatively suffered more
than 4 years from depressive symptoms. A second major reason
might be the early onset of depression during adolescence;
thus, our participating patients may live in a disadvantageous
environment or even have experienced an adverse life event;
hence, epigenetic factors might play a role and might limit
treatment success (2, 39, 40).
Depressive symptoms abated from an initially moderate to
severe to a lower moderate level over the 12 weeks of ICBT with
or without additional face-to-face outpatient psychotherapy.
The follow-up period of 6 months revealed a further decrease of
depressive symptoms in patients having additional face-to-face
outpatient psychotherapy, whereas those patients without
significantly deteriorated—albeit patients of both groups
remained moderate depressive over the period of 6 months.
Therefore, additional face-to-face psychotherapy is strongly
recommended for improved long-term results. However, our
results emphasize the need for more intense and better therapies
including physical activities, environmental approaches, and
pharmacotherapy for chronic depressive patients amenable to
online therapies as overall results are quite disappointing.
Cognitive Behavioral Therapy and
Depression
Cognitive behavioral therapy is the most widely available and
best evident psychotherapy to treat patients with depression
(2, 41). Yet, approximately half of patients do not have access
to treatment because of unawareness of the disease, lacking
capacities of psychotherapists, or the persisting stigma of mental
health disorders (10, 12–14). Thus, a large body of internet-
based therapies is available. Previous studies recommend ICBT
to improve mild to moderate depression, but treatment success
merely persisted over a short period of time; namely, from 6 to
24 months after the ICBT, no group differences were obvious
when compared to an active control condition (42). This previous
reported unsatisfactory long-term effect of ICBT is well in line
with our current results. Therefore, we suggest that future studies
need to evaluate patients’ behavioral and environmental long-
term changes and the effort and time invested in the online
treatment after structured and guided ICBT is applied. Why the
effect of ICBT remained relatively small in our cohort cannot
fully be explained. Nevertheless, the usually rapid effect of ICBT
can be hampered by personality disorders (21, 42). As our patient
cohort experienced first depressive episodes during adolescence
with a high probability of chronic depression, it is possible that
at least part of the cohort suffers from a personality disorder with
negative impact on outcome. One major problem in treatment
of mental disorders is the patient’s individual engagement as up
to one-third of patients discontinue treatment, and of those who
entered continuation phase, 40% break off (13, 20, 43).
Limitations
There are several limitations of our study that warrant
discussion. First, data on previous and current therapies
including pharmacotherapy were not available or incomplete
(43), which limits the interpretability and the discussion of our
results. Second, details on the additional face-to-face outpatient
psychotherapy including the total amount of treatment hours,
the therapeutic focus, and the patient’s individual capabilities to
change maladaptive behaviors or detrimental cognitive beliefs
were incomplete or not assessed. These factors need future
considerations not only because patients with depression having
received twice-weekly compared to once-weekly psychotherapy
are suggested to have an improved outcome (44), but also to
better anticipate the face-to-face psychotherapeutic effect beyond
its frequency. Third, data on the total time spent on face-to-face
or ICBT treatment during the treatment and follow-up period
are incomplete, a weakness that is known from the literature
and needs to be assessed in future studies (45). Fourth, loss to
follow-up was quite high, although representing the common
and well-known problem of depressive patients’ motivation and
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engagement for treatment continuum (43, 44). Fifth, we did
not analyze a control group without any treatment or included
a waiting group; therefore, it cannot fully be excluded that
time influenced at least part of the patient’s improvement (41).
However, there is evidence that ICBT is superior over control
groups and is not only an alternative to watchful waiting (46,
47). Furthermore, application of ICBT is superior to waiting-
list groups with a moderate evidence level (GRADE moderate)
(22), and guided ICBT can be as effective as face-to-face CBT
(48). Sixth, we did not assess environmental factors that might
interfere with treatment effects and need to be included in
future studies.
Future Perspectives
Digital health is rapidly nascent, and a variety of future
perspectives need considerations. First, the most important
direction that needs to be tackled is the use of (i) chatbots
using artificial intelligence and machine learning rather than
decision trees, (ii) embodied conversational avatars, or even (iii)
hackathons that have the potential to increase patients’ therapy
adherence, responsiveness, beneficial behavioral patterns, and
social interactions to overcome depression and to pave the way
to personalized medicine in mental health (49–57). Second,
objective outcome measurements are important to emphasize
the beneficial effect of online therapy trials using neuroimaging,
e.g., diffusion tensor imaging and functional magnetic resonance
imaging, which can help to elucidate microstructural changes
in the white matter tracts of the interhemispheric and frontal-
subcortical neural circuits that are impaired in depression (58),
or to depict the striatal hypoactivation of the reward neuronal
network within unipolar depression when anticipating and
consuming rewards (59), or epigenetic and modifiable factors,
e.g., the dense DNA methylation status of the glucocorticoid
receptor gene (NR3C1), which is associated with early life
stress and disposes to major depression disorder (60). Third,
environmental factors such as previous and current negative
life conditions, marital status, manifestation, and duration of
dysfunctional beliefs might play a role for therapy adherence in
ICBT (61); thus, we advocate to include besides emerging digital
strategies and objective measures more environmental factors in
future studies.
CONCLUSION
During ICBT, QoL and depressive symptoms improved in
patients suffering from moderate to severe depression. At 6
months’ follow-up, patients having received ICBT and additional
face-to-face outpatient psychotherapy were able to stabilize
their improved QoL in contrast to diminished QoL in patients
with sole ICBT and reported significantly reduced depressive
symptoms at the lower border of moderate severity, compared
to slight deterioration of the ICBT patients. These results
suggest additional face-to-face outpatient psychotherapy may
help stabilize outcome over time, and structured and guided
ICBT supports patients having limited access to face-to-face
psychotherapy and/or being afraid of psychiatry-related stigma.
For long-time effects, the continuous treatment of structured
and guided ICBT and/or additional face-to-face psychotherapy
is recommended.
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